中文网站正在持续更新中,请密切关注我们康肽生物的最新动态,或点击访问右上角的英文官方网站 www.phoenixpeptide.com
PHOENIX PHARMACEUTICALS, INC. TOP HOME PAGE
Top » Catalog English Version | My Account | 联系我们 | China



 多肽



 标记多肽 



 多肽激素文库



 抗体 



 免疫试剂盒 



 生物标志物阵列 



 多肽样品检测



 自定义肽链合成及GMP



 产品目录索取



 样品准备



 提问和解答


Neurotensin

Effect of Gastric Bypass and Gastric Banding on Pro-Neurotensin levels in Morbidly Obese Patients.

Context: Neurotensin is produced mainly in the N-cells of the ileum and has a role in appetite regulation; levels are decreased in obese subjects and increase after bariatric surgery. Mature neurotensin is very unstable with a short half-life. Objective: To compare baseline and postoperative levels of the more stable neurotensin precursor, pro-neurotensin/neuromedin (pro-NT/NMN) in patients after gastric banding, gastric bypass, and non-operated controls, respectively, during long-term follow-up. Design and Setting: Prospective observational study in a University Hospital Participants and main outcome measures: Overnight fasting plasma pro-NT/NMN concentrations were measured with a new sandwich immunoassay in morbidly obese subjects at baseline and 3, 6, 12 and 24 months after gastric banding (n = 8), Roux-en-Y gastric bypass (n = 5) and in non-operated controls (n = 7). Results: After gastric bypass and banding, body weight decreased by (mean +/- SD) 29.5 +/- 5.5 kg and 22.8 +/- 5.9 kg, respectively. The decrease after 3 and 6 months was more pronounced after gastric bypass compared with gastric banding (P < 0.05). Plasma pro-NT/NMN levels in patients after gastric bypass increased from 246.3 +/- 174.3 pmol/L on admission to 748.3 +/- 429.6 after 24 months (P < 0.01). In contrast, in patients with gastric banding, pro-NT/NMN concentrations remained stable (207.3 +/- 60.5 pmol/L at admission, 226.6 +/- 116.8 after 24 months). Neither body weight nor plasma pro-NT/NMN levels changed in non-operated controls. Conclusion: Plasma pro-NT/NMN levels show a more pronounced increase after gastric bypass compared with gastric banding, suggesting that specific bariatric surgical procedures result in distinct alterations of gastrointestinal hormone metabolism. The more stable precursor pro-NT/NMN provides a new tool to quantify neurotensin levels in clinical practice.

Christ-Crain M et al. J Clin Endocrinol Metab. 2006 Jun 20; [Epub ahead of print]

Neurotensin EIA Kit (EK-048-03)
Neurotensin Fluorescent EIA Kit (EK-048-03)
Minimum Detectable Concentration = 0.2 ng/ml

Minimum Detectable Concentration = 57 pg/ml
3 times more sensitive than normal EIA kits

%neurotensin%


分类搜索
关键字搜索
按字母搜索
A B C D E F G H I J K L M N
O P Q R S T U V W X Y Z

Copyright © 2024 PHOENIX BIOTECH